![Malavika Babu BSc, MSc](https://profiles-cardiff.imgix.net/attachments/619?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Ms Malavika Babu
(hi/ei)
BSc, MSc
Timau a rolau for Malavika Babu
Cynorthwy-ydd Ymchwil - Ystadegau
Trosolwyg
Gyda gradd ôl-raddedig mewn Bioystadegau, dechreuais fy ngyrfa fel Swyddog Ymchwil Cyswllt yn Adran Bioystadegau Coleg Meddygol Cristnogol, Vellore, India. Ar hyn o bryd rwy'n cael fy nghyflogi fel Cynorthwyydd Ymchwil yn y Ganolfan Ymchwil Treialon (CTR) ym Mhrifysgol Caerdydd, lle rwy'n gweithio ar astudiaethau ym maes iechyd meddwl, clefydau heintus a threialon canser. Rwyf wedi cydweithio ar nifer o brosiectau ymchwil ac wedi cyhoeddi bron i 20 o bapurau ymchwil.
Yn y CTR, rwy'n rhan o'r tîm Ystadegau ac ar hyn o bryd rwy'n cymryd rhan yn yr astudiaethau canlynol fel yr Ystadegydd Treial:
1. Arweiniodd treial rheoledig aml-ganolfan ar hap o raglen heneiddio gweithredol gwirfoddolwr cymheiriaid i atal dirywiad mewn swyddogaeth gorfforol ymhlith pobl hŷn sydd mewn perygl o anabledd symudedd:Treial ACE.
2. AML 18 Treial Canser (https://www.cardiff.ac.uk/centre-for-trials-research/research/studies-and-trials/view/aml18).
Astudiaethau wedi'u cwblhau:
1. Hapdreial rheoledig clwstwr aml-ganolfan i werthuso effeithiolrwydd a chost-effeithiolrwydd KiVa i leihau bwlio mewn ysgolion cynradd: The Stand Together.
2. Treial ar hap, a reolir gan placebo o azithromycin ar gyfer atal clefyd cronig yr ysgyfaint cyn-aeddfedrwydd mewn babanod cynamserol (https://www.cardiff.ac.uk/centre-for-trials-research/research/studies-and-trials/view/aztec).
Mae fy niddordebau ymchwil hefyd yn cynnwys Casgliad Bayesaidd, Dysgu Peiriant, a Dadansoddiad Meta. Adlewyrchir fy ymroddiad i fioystadegau yn fy nysgu a'm cyfraniadau parhaus i'r maes.
Cyhoeddiad
2026
- Knapper, S. et al. 2026. CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18 trial. Blood 147 (10), pp.1048-1057. (10.1182/blood.2025031006)
2025
- Mani, T. et al., 2025. Spatial patterning of hypertension and its association with comorbidities and risk factors: A cross-sectional study in South India. PLoS ONE 20 (12) e0336252. (10.1371/journal.pone.0336252)
- Hutchings, J. et al., 2025. Participants’ roles in bullying among 7–11 year olds: Results from a UK-wide randomized control trial of the KiVa school-based program. Behavioral Sciences 15 (2) 236. (10.3390/bs15020236)
2024
- Bowes, L. et al., 2024. The effects and costs of an anti-bullying program (KiVa) in UK primary schools: a multicenter cluster randomized controlled trial. Psychological Medicine 54 (15), pp.4362-4373. (10.1017/S0033291724002666)
- Lowe, J. et al. 2024. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet Respiratory Medicine 12 (8), pp.608-618. (10.1016/S2213-2600(24)00079-1)
- Prithishkumar, I. J. et al., 2024. Double burden of malnutrition among women of reproductive age: Trends and determinants over the last 15 years in India. PLoS ONE 19 (6) e0304776. (10.1371/journal.pone.0304776)
- Babu, M. et al. 2024. Exact correction factor for estimating the OR in the presence of sparse data with a zero cell in 2 × 2 tables. International Journal of Biostatistics 20 (1), pp.229-243. (10.1515/ijb-2022-0040)
2023
- Joy, M. et al., 2023. Reduction in prevalence of spousal physical violence against women in India: evidence from three national surveys. International Journal of Injury Control and Safety Promotion 30 (3), pp.352-361. (10.1080/17457300.2023.2188468)
- Sappani, M. et al., 2023. Trends in prevalence and determinants of severe and moderate anaemia among women of reproductive age during the last 15 years in India. PLoS ONE 18 (6) e0286464. (10.1371/journal.pone.0286464)
2022
- Loganathan, A. K. et al., 2022. Implementation and outcomes of enhanced recovery protocols in pediatric surgery: a systematic review and meta-analysis.. Pediatric Surgery International 38 , pp.157-168. (10.1007/s00383-021-05008-8)
2021
- Joy, M. et al., 2021. Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries. Clinical Epidemiology and Global Health 9 , pp.202-203. (10.1016/j.cegh.2020.08.015)
- Malavika, B. et al. 2021. Forecasting COVID-19 epidemic in India and high incidence states using SIR and logistic growth models. Clinical Epidemiology and Global Health 9 (Jan-Ma), pp.26-33. (https://doi.org/10.1016/j.cegh.2020.06.006)
- Marimuthu, S. et al., 2021. Modelling of reproduction number for COVID-19 in India and high incidence states. Clinical Epidemiology and Global Health 9 , pp.57-61. (10.1016/j.cegh.2020.06.012)
Erthyglau
- Knapper, S. et al. 2026. CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18 trial. Blood 147 (10), pp.1048-1057. (10.1182/blood.2025031006)
- Mani, T. et al., 2025. Spatial patterning of hypertension and its association with comorbidities and risk factors: A cross-sectional study in South India. PLoS ONE 20 (12) e0336252. (10.1371/journal.pone.0336252)
- Hutchings, J. et al., 2025. Participants’ roles in bullying among 7–11 year olds: Results from a UK-wide randomized control trial of the KiVa school-based program. Behavioral Sciences 15 (2) 236. (10.3390/bs15020236)
- Bowes, L. et al., 2024. The effects and costs of an anti-bullying program (KiVa) in UK primary schools: a multicenter cluster randomized controlled trial. Psychological Medicine 54 (15), pp.4362-4373. (10.1017/S0033291724002666)
- Lowe, J. et al. 2024. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet Respiratory Medicine 12 (8), pp.608-618. (10.1016/S2213-2600(24)00079-1)
- Prithishkumar, I. J. et al., 2024. Double burden of malnutrition among women of reproductive age: Trends and determinants over the last 15 years in India. PLoS ONE 19 (6) e0304776. (10.1371/journal.pone.0304776)
- Babu, M. et al. 2024. Exact correction factor for estimating the OR in the presence of sparse data with a zero cell in 2 × 2 tables. International Journal of Biostatistics 20 (1), pp.229-243. (10.1515/ijb-2022-0040)
- Joy, M. et al., 2023. Reduction in prevalence of spousal physical violence against women in India: evidence from three national surveys. International Journal of Injury Control and Safety Promotion 30 (3), pp.352-361. (10.1080/17457300.2023.2188468)
- Sappani, M. et al., 2023. Trends in prevalence and determinants of severe and moderate anaemia among women of reproductive age during the last 15 years in India. PLoS ONE 18 (6) e0286464. (10.1371/journal.pone.0286464)
- Loganathan, A. K. et al., 2022. Implementation and outcomes of enhanced recovery protocols in pediatric surgery: a systematic review and meta-analysis.. Pediatric Surgery International 38 , pp.157-168. (10.1007/s00383-021-05008-8)
- Joy, M. et al., 2021. Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries. Clinical Epidemiology and Global Health 9 , pp.202-203. (10.1016/j.cegh.2020.08.015)
- Malavika, B. et al. 2021. Forecasting COVID-19 epidemic in India and high incidence states using SIR and logistic growth models. Clinical Epidemiology and Global Health 9 (Jan-Ma), pp.26-33. (https://doi.org/10.1016/j.cegh.2020.06.006)
- Marimuthu, S. et al., 2021. Modelling of reproduction number for COVID-19 in India and high incidence states. Clinical Epidemiology and Global Health 9 , pp.57-61. (10.1016/j.cegh.2020.06.012)
Bywgraffiad
Trosolwg gyrfa:
Rhagfyr 2021 – presennol: Cynorthwy-ydd Ymchwil (Ystadegau), Canolfan Ymchwil Treialon Prifysgol Caerdydd
Hyd 2017 – Hydref 2021: Swyddog Ymchwil Cyswllt, Adran Bioystadegau, Coleg Meddygol Cristnogol, Vellore, TN, India
Aelodaethau proffesiynol
- Cymdeithas Ystadegau Meddygol India (ISMS)
- Cymdeithas Ystadegol America (ASA)
- Cymdeithas Ystadegol Frenhinol (RSS)
Safleoedd academaidd blaenorol
Addysg a chymwysterau:
2015 - 2017: Prifysgol Mahatma Gandhi, India : MSc. Biostatistics– Dosbarth cyntaf gyda rhengoedd thrid prifysgol.
20012- 2015: Prifysgol Mahatma Gandhi, India : BSc. Mathemateg – anrhydedd dosbarth cyntaf
Ymrwymiadau siarad cyhoeddus
- Cymryd rhan a chyflwynodd gyflwyniad poster yng Nghynhadledd Ymchwil Canser Cymru 2024 a drefnwyd gan Ganolfan Ymchwil Canser Cymru ar 4 Mawrth 2024.
- Cymryd rhan a rhoi cyflwyniad llafar yng nghyfarfod yr Ystadegwyr Ifanc (YSM) 2023 a drefnwyd gan Brifysgol Caerlŷr, y Deyrnas Unedig yn ystod 16 – 17 Awst 2023.
- Cymryd rhan a rhoddodd gyflwyniad llafar yn y Gynhadledd Ryngwladol ar Ddatblygiadau Diweddar mewn Methodoleg Ystadegol gyda Chymwysiadau mewn Ystadegau Clinigol a Swyddogol a drefnwyd gan yr Adran Ystadegau a Bioystadegau, Coleg St. Thomas, Pala mewn cydweithrediad â Choleg Meddygol Cristnogol, Vellore a Phrifysgol Maryland, UDA yn ystod 03 – 05 Ionawr 2018.
- Cymryd rhan a rhoddodd gyflwyniad llafar yn y 36ain Gynhadledd Flynyddol ar Gymdeithas Ystadegau Meddygol India (ISMSCON -2018) a drefnwyd gan yr Adran Bioystadegau, NIMHANS, Bengaluru yn ystod 01-03 Tachwedd 2019.
Contact Details
Neuadd Meirionnydd, Llawr 5, Ystafell 509, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4YS